/PRNewswire/ The Prostate Cancer Foundation (PCF) today announced four inaugural Class of 2022 TACTICAL (Therapy ACceleration To Intercept CAncer Lethality).
As cancers grow and potentially spread to new parts of the body, they often shed cells and DNA into the blood stream. DNA can be analyzed for both the amount of DNA present and whether any potential mutations exist that may aid providers in deciding on treatments.